107 related articles for article (PubMed ID: 15658507)
1. Nociceptin/orphanin FQ, hedonic state and the response to abused drugs.
Murphy NP
Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Oct; 24(5):295-8. PubMed ID: 15658507
[TBL] [Abstract][Full Text] [Related]
2. Endogenous nociceptin (orphanin FQ) suppresses basal hedonic state and acute reward responses to methamphetamine and ethanol, but facilitates chronic responses.
Sakoori K; Murphy NP
Neuropsychopharmacology; 2008 Mar; 33(4):877-91. PubMed ID: 17522627
[TBL] [Abstract][Full Text] [Related]
3. Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice.
Sakoori K; Murphy NP
Psychopharmacology (Berl); 2004 Mar; 172(2):129-36. PubMed ID: 14624329
[TBL] [Abstract][Full Text] [Related]
4. Intracerebroventricular orphanin FQ/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats.
Murphy NP; Ly HT; Maidment NT
Neuroscience; 1996 Nov; 75(1):1-4. PubMed ID: 8923516
[TBL] [Abstract][Full Text] [Related]
5. Opioid reward mechanisms: a key role in drug abuse?
Herz A
Can J Physiol Pharmacol; 1998 Mar; 76(3):252-8. PubMed ID: 9673788
[TBL] [Abstract][Full Text] [Related]
6. Nociceptin/orphanin FQ decreases serotonin efflux in the rat brain but in contrast to a kappa-opioid has no antagonistic effect on mu-opioid-induced increases in serotonin efflux.
Tao R; Ma Z; Thakkar MM; McCarley RW; Auerbach SB
Neuroscience; 2007 Jun; 147(1):106-16. PubMed ID: 17499930
[TBL] [Abstract][Full Text] [Related]
7. Endogenous nociceptin modulates diet preference independent of motivation and reward.
Koizumi M; Cagniard B; Murphy NP
Physiol Behav; 2009 Apr; 97(1):1-13. PubMed ID: 19138695
[TBL] [Abstract][Full Text] [Related]
8. Actions of orphanin FQ/nociceptin on rat ventral tegmental area neurons in vitro.
Zheng F; Grandy DK; Johnson SW
Br J Pharmacol; 2002 Aug; 136(7):1065-71. PubMed ID: 12145107
[TBL] [Abstract][Full Text] [Related]
9. Drugs of abuse: biochemical surrogates of specific aspects of natural reward?
Di Chiara G; Acquas E; Tanda G; Cadoni C
Biochem Soc Symp; 1993; 59():65-81. PubMed ID: 7910742
[TBL] [Abstract][Full Text] [Related]
10. The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.
Wee S; Koob GF
Psychopharmacology (Berl); 2010 Jun; 210(2):121-35. PubMed ID: 20352414
[TBL] [Abstract][Full Text] [Related]
11. Daily intravesical instillation of 1 mg nociceptin/orphanin FQ for the control of neurogenic detrusor overactivity: a multicenter, placebo controlled, randomized exploratory study.
Lazzeri M; Calò G; Spinelli M; Malaguti S; Guerrini R; Salvadori S; Beneforti P; Regoli D; Turini D
J Urol; 2006 Nov; 176(5):2098-102. PubMed ID: 17070267
[TBL] [Abstract][Full Text] [Related]
12. The nociceptin/orphanin FQ system as a target for treating alcoholism.
Murphy NP
CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):87-93. PubMed ID: 20201819
[TBL] [Abstract][Full Text] [Related]
13. Endogenous opiates and behavior: 2012.
Bodnar RJ
Peptides; 2013 Dec; 50():55-95. PubMed ID: 24126281
[TBL] [Abstract][Full Text] [Related]
14. Hedonic and motivational roles of opioids in food reward: implications for overeating disorders.
Peciña S; Smith KS
Pharmacol Biochem Behav; 2010 Nov; 97(1):34-46. PubMed ID: 20580734
[TBL] [Abstract][Full Text] [Related]
15. Minireview: Characterization of influence of central nociceptin/orphanin FQ on consummatory behavior.
Olszewski PK; Levine AS
Endocrinology; 2004 Jun; 145(6):2627-32. PubMed ID: 15044361
[TBL] [Abstract][Full Text] [Related]
16. Nociceptin/orphanin FQ modulation of rat midbrain dopamine neurons in primary culture.
Murphy NP; Tan AM; Lam HA; Maidment NT
Neuroscience; 2004; 127(4):929-40. PubMed ID: 15312905
[TBL] [Abstract][Full Text] [Related]
17. Endogenous opioids and addiction to alcohol and other drugs of abuse.
Gianoulakis C
Curr Top Med Chem; 2009; 9(11):999-1015. PubMed ID: 19747123
[TBL] [Abstract][Full Text] [Related]
18. Ovarian sex steroid-dependent plasticity of nociceptin/orphanin FQ and opioid modulation of spinal dynorphin release.
Gupta DS; Kelson AB; Polgar WE; Toll L; Szücs M; Gintzler AR
J Pharmacol Exp Ther; 2001 Sep; 298(3):1213-20. PubMed ID: 11504823
[TBL] [Abstract][Full Text] [Related]
19. Conditioned opioid withdrawal decreases nociceptin/orphanin FQ levels in the frontal cortex and olfactory tubercle.
Walker JR; Terenius L; Koob GF
Neuropsychopharmacology; 2002 Aug; 27(2):203-11. PubMed ID: 12093594
[TBL] [Abstract][Full Text] [Related]
20. Evidence for opioid involvement in the motivation to sing.
Riters LV
J Chem Neuroanat; 2010 Mar; 39(2):141-50. PubMed ID: 19995531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
